This educational activity is designed for surgical dermatologists, Mohs surgeons, dermatologists, and other healthcare professionals who manage patients with advanced or metastatic basal cell carcinoma or cutaneous squamous cell carcinoma. Our goal is to help these clinicians better explain the risk assessment of patients with non-melanoma skin cancers (NMSCs) who may derive optimal benefit with new systemic therapies when compared to Mohs surgery, incorporate patient trials data for systemic immunotherapy into the treatment of both advanced cutaneous squamous cell carcinoma and basal cell carcinoma, and collaborate with other members of the NMSC healthcare team to provide a multidisciplinary approach to the development of treatment plans for individuals with high-risk NMSCs.

RELEASED DATE: June 10, 2025
EXPIRATION DATE: June 10, 2026

With multiple immunotherapy treatment options and combinations available for the management of melanoma, clinicians require up-to-date guidance on the application of clinical data—including recent findings presented at ASCO—to support shared decision-making and multidisciplinary care. In this concise program, Dr. Emily Ruiz reviews current evidence-based guidelines, presents clinical data informing treatment decisions, and demonstrates best practices for applying this data to patients with melanoma.

RELEASED DATE: July 31, 2025
EXPIRATION DATE: July 31, 2026